IART
NASDAQ
US
Integra LifeSciences Holdings Corporation - Common Stock
$9.53
▼ $-0.04
(-0.42%)
Vol 634K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$967.4M
ROE
-38.5%
Margin
-30.2%
D/E
176.48
Beta
1.05
52W
$11–$27
Wall Street Consensus
16 analysts · Apr 20262
Strong Buy
1
Buy
7
Hold
3
Sell
3
Strong Sell
18.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.82 | $0.83 | +$0.01 |
| Sep 2025 | $0.44 | $0.54 | +$0.10 |
| Jun 2025 | $0.44 | $0.45 | +$0.01 |
| Mar 2025 | $0.44 | $0.41 | $-0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $442.6M | $382.7M | $415.6M | $402.1M | $434.9M |
| Net Income | — | $19.4M | -$25.3M | -$484.1M | -$5.4M | -$1.7M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -35.6% | -35.6% | -35.6% | -38.5% | -38.5% | -38.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -116.5% | -30.9% | -30.9% | -30.1% | -30.1% | -30.1% |
| Gross Margin | 55.1% | 57.2% | 57.2% | 57.2% | 57.2% | 57.2% |
| D/E Ratio | 177.18 | 177.18 | 177.18 | 176.48 | 176.48 | 176.48 |
| Current Ratio | 1.23 | 1.23 | 1.23 | 3.14 | 3.14 | 3.14 |
Key Ratios
ROA (TTM)
-12.9%
P/S (TTM)
0.59
P/B
1.1
EPS (TTM)
$-6.46
CF/Share
$2.73
Rev Growth 3Y
+1.5%
52W High
$27.13
52W Low
$10.87
$10.87
52-Week Range
$27.13
Financial Health
Free Cash Flow
-$19.6M
Net Debt
$1.8B
Cash
$235.0M
Total Debt
$2.0B
As of Dec 31, 2025
How does IART compare to Health Care peers?
Peer group: Micro-cap Health Care (All) · 241 companies
IART valuation vs Health Care peers
P/E ratio
—
▼
0%
below
peers
(30.7)
vs Peers
vs Industry
Undervalued
P/S ratio
0.6
▼
77%
below
peers
(2.6)
vs Peers
vs Industry
Undervalued
P/B ratio
1.1
▼
59%
below
peers
(2.8)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.7%)
vs Peers
vs Industry
Low yield
IART profitability vs Health Care peers
ROE
-38.5%
▲
0%
above
peers
(-38.5%)
vs Peers
vs Industry
In line
Net margin
-30.2%
▼
22%
below
peers
(-24.7%)
vs Peers
vs Industry
Below avg
Gross margin
57.2%
▲
8%
above
peers
(52.9%)
vs Peers
vs Industry
In line
ROA
-12.9%
▲
39%
above
peers
(-21.2%)
vs Peers
vs Industry
Below avg
IART financial health vs Health Care peers
D/E ratio
176.5
▲
815%
above
peers
(19.3)
vs Peers
vs Industry
High debt
Current ratio
3.1
▲
45%
above
peers
(2.2)
vs Peers
vs Industry
Below avg
Beta
1.1
▲
0%
above
peers
(1.1)
vs Peers
vs Industry
Less volatile
IART fundamentals radar
IART
Peer median
Industry
IART profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IART vs peers: key metrics
Latest News
No related news yet